Mustafa Demirpence

Izmir, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Journal: Obesity facts

Published: February 11, 2026

Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea.

Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea.

Journal: Endokrynologia Polska

Published: July 29, 2023

DO ANDROGENS PREDICT CARDIOVASCULAR RISK INCLUDING CARDIOTROPHIN-1 LEVELS in PATIENTS WITH OBESE and LEAN POLYCYSTIC OVARY SYNDROME.

DO ANDROGENS PREDICT CARDIOVASCULAR RISK INCLUDING CARDIOTROPHIN-1 LEVELS in PATIENTS WITH OBESE and LEAN POLYCYSTIC OVARY SYNDROME.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)

Published: May 08, 2023

Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome.

Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome.

Journal: Endokrynologia Polska

Published: December 28, 2022

Are patients with obesity "scapegoats"? The obesity prejudice levels of health care workers in Turkey.

Are patients with obesity "scapegoats"? The obesity prejudice levels of health care workers in Turkey.

Journal: Revista da Associacao Medica Brasileira (1992)

Published: July 26, 2021

Serum neudesin levels in patients with polycystic ovary syndrome.

Serum neudesin levels in patients with polycystic ovary syndrome.

Journal: Ginekologia polska

Published: January 13, 2021

Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly.

Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly.

Journal: Hormones (Athens, Greece)

Published: April 12, 2019

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism.

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism.

Journal: Archives of endocrinology and metabolism

Published: February 02, 2018

Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?

Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?

Journal: Journal of endocrinological investigation

Published: December 31, 2017

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin.

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin.

Journal: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Published: November 15, 2017

THE EFFECT OF EXENATIDE THERAPY IN PREVIOUSLY INSULIN-TREATED TYPE 2 DIABETIC PATIENTS.

THE EFFECT OF EXENATIDE THERAPY IN PREVIOUSLY INSULIN-TREATED TYPE 2 DIABETIC PATIENTS.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)

Published: October 01, 2017

Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.

Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.

Journal: Northern clinics of Istanbul

Published: June 03, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026